BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 26241876)

  • 1. Triazine as a promising scaffold for its versatile biological behavior.
    Singla P; Luxami V; Paul K
    Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
    Verma T; Sinha M; Bansal N
    Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Updates on the Chemistry and Biological Roles of Thiazine Scaffold: A Review.
    Choudhary S; Silakari O; Singh PK
    Mini Rev Med Chem; 2018; 18(17):1452-1478. PubMed ID: 29663882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review.
    Kumar R; Singh AD; Singh J; Singh H; Roy RK; Chaudhary A
    Mini Rev Med Chem; 2014 Jan; 14(1):72-83. PubMed ID: 24387709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():74-86. PubMed ID: 28615111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic advancement of benzothiazole derivatives in the last decennial period.
    Tariq S; Kamboj P; Amir M
    Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800170. PubMed ID: 30488989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of triterpenoid triazine derivatives from allobetulone and betulonic acid with biological activities.
    Dinh Ngoc T; Moons N; Kim Y; De Borggraeve W; Mashentseva A; Andrei G; Snoeck R; Balzarini J; Dehaen W
    Bioorg Med Chem; 2014 Jul; 22(13):3292-300. PubMed ID: 24844757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
    Liu H; Long S; Rakesh KP; Zha GF
    Eur J Med Chem; 2020 Jan; 185():111804. PubMed ID: 31675510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolo[4,5-d]pyrimidines as a privileged scaffold in drug discovery.
    Kuppast B; Fahmy H
    Eur J Med Chem; 2016 May; 113():198-213. PubMed ID: 26942627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
    Abdellatif KRA; Bakr RB
    Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Privileged s-triazines: structure and pharmacological applications.
    Shah DR; Modh RP; Chikhalia KH
    Future Med Chem; 2014 Mar; 6(4):463-77. PubMed ID: 24635525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities.
    Singh S; Mandal MK; Masih A; Saha A; Ghosh SK; Bhat HR; Singh UP
    Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000363. PubMed ID: 33760298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazole Derivatives as Potential Therapeutic Agents.
    Sharma A; Kumar V; Kharb R; Kumar S; Sharma PC; Pathak DP
    Curr Pharm Des; 2016; 22(21):3265-301. PubMed ID: 26916016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive Benzofuran derivatives: A review.
    Khanam H; Shamsuzzaman
    Eur J Med Chem; 2015 Jun; 97():483-504. PubMed ID: 25482554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications.
    Kushwaha N; Sharma CS
    Mini Rev Med Chem; 2020; 20(20):2104-2122. PubMed ID: 32727324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,4-triazine analogs as novel class of therapeutic agents.
    Kumar R; Sirohi TS; Singh H; Yadav R; Roy RK; Chaudhary A; Pandeya SN
    Mini Rev Med Chem; 2014 Feb; 14(2):168-207. PubMed ID: 24479860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
    Guo H; Diao QP
    Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of some new heterobicyclic compounds containing spiro-1,2,4-triazine moiety as potential anti HIV and anticancer agents.
    Abdel-Rahman RM; Seada M; Fawzy M; el-Baz I
    Boll Chim Farm; 1994 Jun; 133(6):374-80. PubMed ID: 7917184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
    Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
    Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.